Archive - October 2021
EMA nod for excessive daytime sleepiness med Ozawade
FDA panel OK’s Pfizer/BioNTech jab for children aged five to 11
Record 1.6 million receive COVID-19 boosters over seven days
Strategic collaboration strengthens lupus clinical research in UK
New collaboration to develop next-gen diagnostic platform for early cancer detection
Eli Lilly focuses on 2022 launches as revenues climb by 18%
Eli Lilly focuses on 2022 launches as revenues climb by 18%
Priority review for Novartis CAR-T cell therapy Kymriah